Insider Trading History of Deptula-hicks Darlene M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Deptula-hicks Darlene M since 2010. The trader's CIK number is 1089409. At the time of the last reporting, Deptula-hicks Darlene M was the Executive VP of Finance, CFO of T2 Biosystems, Inc.. (stock ticker symbol TTOO). Also see all insider trading activities at T2 Biosystems, Inc..

Note that in the past DEPTULA-HICKS DARLENE M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pieris Pharmaceuticals, Inc. (PIRS) by Deptula-hicks Darlene M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 PIRS 5,000 $8,300 0 $0 0 $0

Yearly summary of insider trading at Icad Inc (ICAD) by Deptula-hicks Darlene M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 ICAD 0 $0 25,000 $35,026 0 $0

Yearly summary of insider trading at T2 Biosystems, Inc. (TTOO) by Deptula-hicks Darlene M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 TTOO 4,000 $14,320 0 $0 0 $0


Insider trading activities at 3 companies by Deptula-hicks Darlene M:

1. Pieris Pharmaceuticals, Inc. (PIRS)

2. Icad Inc (ICAD)

3. T2 Biosystems, Inc. (TTOO)

Table 1. Insider trading of Pieris Pharmaceuticals, Inc. (PIRS) by Deptula-hicks Darlene M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-06-13 PIRS Buy 5,000 1.66 8,300

Table 2. Insider trading of Icad Inc (ICAD) by Deptula-hicks Darlene M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-03-11 ICAD Sale 19,629 1.40 27,480
2010-03-10 ICAD Sale 5,170 1.41 7,263
2010-03-09 ICAD Sale 201 1.41 283

Table 3. Insider trading of T2 Biosystems, Inc. (TTOO) by Deptula-hicks Darlene M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-06-06 TTOO Buy 4,000 3.58 14,320

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deptula-hicks Darlene M (Executive VP of Finance, CFO of T2 Biosystems, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.